Background: Diffuse gliomas are highly aggressive brain tumors that invariably relapse despite treatment with chemo-and radiotherapy. Treatment with alkylating chemotherapy can drive tumors to develop a hypermutator phenotype. In contrast, the genomic effects of radiotherapy (RT) remain unknown.Methods: We analyzed the mutational spectra following treatment with RT in whole genome or exome sequencing data from over > 4,000 samples, including 190 paired primary-recurrent gliomas from the Glioma Longitudinal Analysis (GLASS) dataset and 3693 post-treatment metastatic tumors from the Hartwig Medical Foundation.Results: We identified a significant increase in the burden of small deletions following radiation therapy that was independent of other factors (P¼3e-03, log-linear regression model). These novel deletions demonstrated distinct characteristics when compared to pre-existing deletions present prior to RT-treatment and deletions in RTuntreated tumors. Radiation therapy-acquired deletions were characterized by a larger deletion size (GLASS and HMF, P¼1.5e-04 and P¼6e-16, respectively; Mann-Whitney U test), an increased distance to repetitive DNA elements (P<2.2e-16, Kolmogorov-Smirnov test) and a lack of microhomology at breakpoints (P ¼ 6.6e-05, paired Wilcoxon signed-rank test). These observations suggested that canonical non-homologous end joining (c-NHEJ) was the preferred pathway for DNA double strand break repair of RT-induced DNA damage. Furthermore, radiotherapy resulted in frequent chromosomal deletions and significantly increased frequencies of CDKN2A homozygous deletions in IDHmut glioma (P¼1.9e-05, Fisher's exact test). Finally, a high burden of RT-associated deletions was associated with worse clinical outcomes (GLASS and HMF, P¼3.4e-02 and P<1e-04, respectively; log-rank test).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.